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Abstract
Background: Electroacupuncture (EA), as an extension technique of acupuncture based on traditional acupuncture
combined with modern electrotherapy, is commonly used for stroke in clinical treatment and researches. However,
there is still a lack of enough evidence to recommend the routine use of EA for stroke. This study is aimed at
evaluating the quality of reporting of randomized controlled trials (RCTs) on EA for stroke.
Methods: RCTs on EA for stroke were evaluated by using CONSORT guidelines and STRICTA guidelines. Microsoft
Excel 2010 and the R software were used for descriptive statistics analyses.
Results: Seventy studies involving 5468 stroke patients were identified. The CONSORT scores ranged from 16.2 to 67.6%
and STRICTA scores from 29.4 to 82.4%. The central items in CONSORT as eligibility criterion, sample size calculation,
primary outcome, method of randomization sequence generation, allocation concealment, implementation of
randomization, description of blinding, and detailed statistical methods were reported in 100, 6, 68, 37, 14, 10, 16,
and 97% of trials, respectively. The reporting of items in STRICTA as acupuncture rationale was 1a (91%), 1b (86%)
and 1c 0%; needling details 2a (33%), 2b (97%), 2c (29%), 2d (64%), 2e (100%), 2f (55%) and 2 g (66%); treatment
regimen 3a (69%) and 3b (100%); other components of treatment 4a (86%) and 4b (13%); practitioner background item
5 (16%); control intervention(s) 6a (93%) and 6b (10%).
Conclusions: The quality of reporting of RCTs on EA for stroke was generally moderate. The reporting quality needs
further improvement.
Keywords: Electroacupuncture, Stroke, Randomized controlled trial, Methodology
Background
Stroke is a major cause of death and disability in both de-
veloped and developing countries worldwide. Thromboly-
sis with intravenous recombinant tissue-type plasminogen
activator therapy remains the only proven effective
pharmacological treatment for selected acute ischemic
stroke patients within a relatively short therapeutic time
window of 3 to 4.5 h after the onset of stroke symptoms
[1]. Furthermore, the major risk of intravenous thromb-
olysis treatment also remains the symptomatic intracranial
hemorrhage, which is a devastating complication with
high mortality. What’s more, the enormous morbidities of
ischemic stroke result from the interplay between the
resulting neurological impairment, the emotional and so-
cial consequences of that impairment, and the high risk
for recurrence [2]. Owing to the significant health risk of
stroke and the limitations of currently available conven-
tional therapies, unprecedented attention has been at-
tached to complementary and alternative medicine
(CAM) worldwide due to its potential efficacy on stroke.
Acupuncture is one of the most commonly used CAM
therapies for stroke around the world. Up to now, at
least 24 systematic reviews have been published, the
available evidence suggests that acupuncture is effective
for improving some aspects of poststroke neurological im-
pairment and dysfunction, although there was insufficient
evidence for stroke in preventing poststroke death [3]. Es-
pecially, electroacupuncture (EA) is an extension tech-
nique of acupuncture based on traditional acupuncture
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combined with modern electrotherapy [4]. There are
many advantages of EA such as the readily quantifiable
parameters for stimulation as frequency, intensity and
duration, and the therapeutic benefit of EA is commonly
identified to be equivalent to manual acupuncture [5]. In
some situations, EA has been shown to be more effective
than manual acupuncture, particularly when strong, con-
tinued stimulation was required, as when treating stroke
[6]. Thus, EA is commonly used in current clinic and re-
search. A systematic review from our team has indicated
that the available evidence potentially supported the use
of EA for acute ischemic stroke [4]. However, there is still
a lack of enough evidence to recommend the routine use
of EA for stroke.
Both systematic reviews of high-quality randomized
controlled trials (RCTs) and RCT itself, especially those
with double-blind placebo controls, are commonly
regarded the highest level of evidence in judging the
treatment efficacy and safety of interventions. The cred-
ibility of the evidence in support of a treatment ap-
proach depends on the quality of RCTs. However, a
large body of evidence indicated that the quality of
reporting of RCTs remains sub-optimal [7]. Researchers
have accumulated and suggested that the RCTs which
were of poor methodological quality tend to exaggerate
the treatment effects and result in misleading in health
care at all levels [8]. So far, two studies have already been
conducted to evaluate the quality of reporting of RCTs
on acupuncture for stroke. In 2006, one study [9] dem-
onstrated that the quality of reporting of 74 RCTs on
acupuncture for acute stroke was generally poor. In
2014, another study [10] indicated that the quality of
reporting of only 15 RCTs on acupuncture for subacute
and chronic stroke was improved but some central items
were still insufficiently or inadequately reported in most
of the studies. However, no study has yet been con-
ducted to assess the quality of reporting RCTs on EA for
stroke. Thus, this study aimed at evaluating the quality
of reporting of RCTs on EA for stroke according to the
consolidated standards of reporting trials (CONSORT)
statement [11] and the standards for reporting interven-
tions in clinical trials of acupuncture (STRICTA) state-
ment [12].
Methods
Information sources and search
Eight English and Chinese databases were electronically
searched from their inceptions to June 2014. They are
Cochrane Controlled Trials Register, PubMed, EMBASE,
AMED, China National Knowledge Infrastructure(CNKI),
VIP Journals Database, Wanfang Database and Chinese
Biomedical Database(CBM). The search terms were listed
as follows: “electroacupuncture AND (stroke OR apoplexy
OR cerebrovascular accident OR cerebrovascular attack
OR cerebral infarction OR intracerebral hemorrhage OR
cerebral vascular disease)”. Chinese databases were also
searched using the above corresponding search terms in
Chinese.
Eligibility criteria
All RCTs on EA as monotherapy or adjunct therapy for
stroke compared with at least one control group as no
treatment, sham/placebo EA or conventional treatment,
regardless of publication status or language, were se-
lected. The diagnostic criteria of stroke were clinically in
accordance with the World Health Organization
definition [13]. The diagnosis of stroke was confirmed
by CT and/or MRI.
Exclusion criteria
Studies concerning EA therapy for paresthesia, post-
strokedepression, bulbar paralysis and other non-functional
dysfunction were excluded. Additional exclusion criteria
were animal experiment, case report, review, single-arm
study, retrospective study and historical control study, du-
plicated publications, and quasi-randomized trial. Crossover
and cluster RCTs were excluded because of the employ-
ment of the CONSORT guidelines for parallel RCTs.
Searches were limited to English and Chinese publications.
Data extraction
Two investigators underwent training in studying every
item and multiple subitems listed in CONSORT2010 and
STRICTA2010 to ensure the proper understanding of
each standard. Each report was reviewed by two inde-
pendent investigators. They extracted information accord-
ing to CONSORT2010 and STRICTA2010 checklists.
“1”or “0” was scored by the two authors independently to
represent whether the RCT had reported the relevant
item/subitem or not. “0” indicates no description of the
corresponding item/subitem and “1” indicates that the au-
thor had mentioned the description of the item/subitem
in the report. Investigators resolved discrepancies by
consensus or consultations during the data-extraction
process.
Data analyses
Microsoft Excel 2010 and R software (Version 3.1.1)
were used for descriptive statistics analyses. The overall
number of RCTs which corresponded with each item
was counted. Subsequently results were represented as
the percentage, and 95% confidence interval (CI) of each
overall rate was calculated. We also classified the included
studies into two groups according to which language they
were published in Chinese or English. Proportions of re-
ported items in two groups were compared using inde-
pendent sample Student’s t-test. Statistical calculations
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were performed by using SPSS (version 17.0). Level of
significance was set at P < 0.05.
Results
Study selection
A total of 2662 potentially relevant articles were identi-
fied. By reviewing titles and abstracts, 2168 papers were
excluded for at least one of following reasons: (1) dupli-
cate publication, (2) animal study, (3) not clinical trial,
and (4) case report. After examining the remaining 494
literatures through reading the full text, we removed 424
papers. Of which, 61 were non-randomized controlled
trials, 11 were not focusing on functional rehabilitation
or with other indicators, 41 were about other diseases or
using an ambiguous diagnostic criteria, 17 duplicate
publications, and 294 studies with other reasons. Even-
tually, 70 eligible RCT studies [14–83] were selected for
the final analysis (Fig. 1).
Study characteristics
Seventy studies (one article was designed with 2 compar-
isons) involving 5468 stroke patients were identified. For
the 5468 patients, there were 2420 male and 1739 fe-
male, and with the ages ranging from 24 to 89 years old.
However, the gender and age of the remaining 1309
participants could not be obtained from the primary
data. Sample sizes ranged from 6 to 160 participants. In
40 studies EA was used for cerebral infarction, while in
the other 30 studies EA was used for both cerebral in-
farction and intracerebral hemorrhage (ICH). Seventeen
studies were published in English, and the other 53 stud-
ies were published in Chinese. Six studies were online
Master’s thesis and not formally published [17, 40, 64,
65, 81, 82]. For the control group, WCTs were used in
62 studies and sham EA plus WCTs in 8 studies. The
duration of treatment varied from 10 days to 12 weeks.
Six studies conducted follow-up assessment with
duration from 6 weeks to 12 months. Four studies con-
ducted sample size calculation [20, 23, 34, 63]. Twenty-
one studies reported adverse effects. In 11 studies, the
discripion of the professional acupuncturists who partic-
ipated in the studies was very simple and without de-
tailed background. Nine studies reported informed
consent from patients [20, 23, 24, 27, 33, 34, 64, 65, 71].
Only 6 study [27, 50, 62, 64, 65, 74] reported ethical
approval. Key data are summarized in Table 1.
Items reported according to CONSORT statement
The items reported from the 70 RCTs according to
CONSORT statement are summarized in Table 2.
Fig. 1 Flow diagram for the selection of articles for inclusion in the study
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Table 2 The reporting number and percentage for each item of the CONSORT checklist of the included 70 studies
Section/Topic Item No Checklist item n % (n /70) 95%CI
Title and abstract 1a Identification as a randomized trial in the title 12 17 [9 to 28]
1b Structured summary of trial design, methods, results, and
conclusions (for specific guidance see CONSORT for abstracts)
54 77 [66 to 86]
Introduction
Background and objectives 2a Scientific background and explanation of rationale 63 90 [80 to 96]
2b Specific objectives or hypotheses 65 93 [84 to 98]
Methods
Trial design 3a Description of trial design (such as parallel, factorial) including
allocation ratio
58 83 [72 to 91]
3b Important changes to methods after trial commencement
(such as eligibility criteria), with reasons
0 0 [0 to 5]
Participants 4a Eligibility criteria for participants 70 100 [95 to 100]
4b Settings and locations where the data were collected 58 83 [72 to 91]
Interventions 5 The interventions for each group with sufficient details to allow
replication, including how and when they were actually administered
70 100 [95 to 100]
Outcomes 6a Completely defined pre-specified primary and secondary outcome
measures, including how and when they were assessed
68 97 [90 to 100]
6b Any changes to trial outcomes after the trial commenced, with reasons 1 1 [0 to 8]
Sample size 7a How sample size was determined 4 6 [2 to 14]
7b When applicable, explanation of any interim analyses and stopping guidelines 7 10 [4 to 20]
Randomisation
Sequence generation 8a Method used to generate the random allocation sequence 26 37 [26 to 50]
8b Type of randomization; details of any restriction (such as blocking
and block size)
20 29 [18 to 41]
Allocation concealment
mechanism
9 Mechanism used to implement the random allocation sequence
(such as sequentially numbered containers), describing any steps
taken to conceal the sequence until interventions were assigned
10 14 [7 to 25]
Implementation 10 Who generated the random allocation sequence, who enrolled
participants, and who assigned participants to interventions
7 10 [4 to 20]
Blinding 11a If done, who was blinded after assignment to interventions
(for example, participants, care providers, those assessing
outcomes) and how
11 16 [8 to 27]
11b If relevant, description of the similarity of interventions 6 9 [3 to 18]
Statistical methods 12a Statistical methods used to compare groups for primary
and secondary outcomes
68 97 [90 to 100]
12b Methods for additional analyses, such as subgroup analyses
and adjusted analyses
0 0 [0 to 5]
Results
Participant flow (a diagram is
strongly recommended)
13a For each group, the numbers of participants who were randomly
assigned, received intended treatment, and were analysed for
the primary outcome
5 7 [2 to 16]
13b For each group, losses and exclusions after randomization,
together with reasons
15 21 [13 to 33]
Recruitment 14a Dates defining the periods of recruitment and follow-up 44 63 [50 to 74]
14b Why the trial ended or was stopped 2 3 [0 to 10]
Baseline data 15 A table showing baseline demographic and clinical
characteristics for each group
23 33 [22 to 45]
Baseline data 16 For each group, number of participants (denominator) included
in each analysis and whether the analysis was by original
assigned groups
57 81 [70 to 90]
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Title and abstract
Twelve (18%) trials can be identified as random trials
after reviewing the title (1a), among which 8 were in
English. Fifty-four (77%) articles had abstracts that were
comprised of objective, methods, results and conclu-
sions (1b).
Introduction
Of the included studies, 90% provided the detailed de-
scription of backgrounds (2a). The proportion of studies
with objectives (2b) was 93%.
Methods
Only 2 CONSORT items were described in all the in-
cluded articles. One was the eligibility criterion for par-
ticipants (4a) and the other was the interventions for
each group with sufficient details to allow replication, in-
cluding how and when they were actually administered
(5). However, the proportion on the description of the
patient’s allocation ratio was 58% (3a). None of the arti-
cles (0%) described the important changes after the be-
ginning of the trial because of the recruitment (3b).
Fifty-eight reports (83%) described the settings and loca-
tions where the data were collected (4b). The proportion
on the description of definition of primary/secondary
outcomes was 68% (6a). Four (6%) reports mentioned
the method of how to determine the sample size (7a).
Items on incomplete reporting were 1% (subitem 6b)
and 10% (subitem 7b).
Randomization
Twenty studies (29%) mentioned the type of randomization
as the simple random method (8b). However, the propor-
tion of the description on sequence generation was 37%
(8a), which used computer or random number table. Ten
articles (14%) described the hidden mechanism by the use
of opaque envelopes aiming to implement the allocation
concealment (9). The detailed implementation was given in
7 articles (10%) (10). A total of 11 articles (16%) provided
the description of blinding (11a), among which one was
double blind (participants and evaluators) and the others
were single-blind assessment. Sixty-eight studies (97%) pro-
vided the description of detailed statistical methods (12a),
but no one provided methods for additional analyses (12b).
Result and discussion
Nine studies (13%) described the treatment progress of
participants by a diagram (13a). Fifteen (21%) of these
articles mentioned the number of the losses and exclu-
sions after randomization with explanations (13b).
Forty-four studies (63%) mentioned the periods of re-
cruitment, but only 6 studies described the follow-up
duration (14a). Two articles had reported a temporal
interruption of the therapy because of the drop out of
participants with personal reasons. Thirty-four reports
(49%) offered the description of baseline data that in-
cluded underlying disease or basic demographic or clin-
ical characteristics, among which 23 studies (33%)
represented the data in the form of a table (15). Fifty-
seven studies (81%) described the statistics methods,
Table 2 The reporting number and percentage for each item of the CONSORT checklist of the included 70 studies (Continued)
Outcomes and estimation 17a For each primary and secondary outcome, results for each group,
and the estimated effect size and its precision (such as 95%
confidence interval)
2 3 [0 to 10]
17b For binary outcomes, presentation of both absolute and relative
effect sizes is recommended
0 0 [0 to 5]
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses
and adjusted analyses, distinguishing pre-specified from exploratory
1 1 [0 to 8]
Harms 19 All important harms or unintended effects in each group
(for specific guidance see CONSORT for harms)
21 30 [20 to 42]
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and,
if relevant, multiplicity of analyses
10 14 [7 to 25]
21 Generalisability (external validity, applicability) of the trial findings 13 19 [10 to 30]
Interpretation 22 Interpretation consistent with results, balancing benefits and harms,
and considering other relevant evidence
22 31 [21 to 44]
Other information
Registration 23 Registration number and name of trial registry 0 0 [0 to 5]
Protocol 24 Where the full trial protocol can be accessed, if available 1 1 [0 to 8]
Funding 25 Sources of funding and other support (such as supply of drugs),
role of funders
14 20 [11 to 31]
Total mean scorea 13.0 ± 4.0
aMean ± SD
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including the use of intention-to-treat analysis (16). Almost
all outcomes of the included reports were presented as the
ratio of efficiency or means ± SD. Two papers (3%) applied
95% CI to describe the estimated value of the effect and its
precision (17a). No study reported binary outcomes (17b).
One study provided a kind of secondary analyses as “error
type I” in statistics (18). In discussion section, 21 papers
(30%) reported the occurrence of adverse events, such as
acupuncture syncope, infection of puncture site and death
(19). The proportions of papers reporting limitation (20),
generalisability (21) and interpretation (22) were 14, 19,
and 31%, respectively.
Other information: None of the papers reported the
registration (23). Only 1 report (1%) gave the relevant
electronic links for the obtainment of protocol (24).
The proportion of paper with reporting of funding (25)
was 420%.
Items reported according to STRICTA statement
The items reported from the 70 RCTs according to
STRICTA statement are summarized in Table 3.
Acupuncture rationale
Apart from several English articles, majority of the other
included articles (91%) used the style of acupuncture
from Traditional Chinese Medicine (1a). Eighty-six per-
cent of the reports provided reasons for treatment based
on historical context, literature sources, citing references
where appropriate, and so on (1b). None of the studies
had mentioned any alteration of the treatment after the
beginning of the experiments (1c).
Needling details
Various intervention methods were used in EA treat-
ment group, and were mainly as follows: EA plus con-
ventional theory, EA plus acupoint injection, scalp EA
plus acupoint injection, and EA plus internal carotid in-
jection. All the 70 included reports provided the type of
needle stimulation, including electrical acupuncture or
electrical acupuncture combined with manual acupunc-
ture (2e). Ninety seven percent of articles listed the
names (or location if no standard name) of acupoints
used at the uni/bilateral sides (2b); however, only 33%
articles mentioned the number of needles, 33% (2a).
Twenty nine percent of studies mentioned the depth of
needle insertion (2c). The other STRICTA items on
needling details were response elicited (de qi or muscle
twitch response), 64% (2d), needle retention time, 55%
(2f ) and needle type, 66% (2 g).
Treatment regimen
All the reports mentioned the frequency and duration of
treatment sessions (3b), whereas 69% articles provided
the number of treatment sessions (3a).
Cointerventions
One item, details of other interventions, was mentioned
in more than half of the reports, 86% (4a). Nine reports
(13%) described some relevant information and explana-
tions to patients, including informed consent (4b).
Practitioner background
Eleven articles (16%) provided vague and unspecific de-
scription on the background of acupuncturist which in-
cluded expertise, duration of training and length of
clinical experience (5). In the 11 articles, four mentioned
that the acupuncturists were professionals, and the
others mentioned the contents as expertise or duration
of specific training.
Control intervention(s)
A total of 93% trials reported a precise description of the
control or comparator (6b). Furthermore, 8 studies used
sham EA as control with providing further details of
items 1 to 3 in STRICTA. Ten percent of studies pro-
vided the quoted data to elucidate the rationality of con-
trasting and comparing other similar experiments (6a).
Comparison of reporting quality between Chinese and
English studies
The total mean score in CONSORT items failed to
achieve significant differences between English studies
and Chinese studies (English vs. Chinese: 15.2 ± 4.3 vs.
12.3 ± 3.6, p = 0.05), Table 4. However, there is statisti-
cally significant improvement in three items published
in English vs. in Chinese as follows: (1a) title (56% vs.6%,
p = 0.01), (11a) blinding (44% vs. 7%, p = 0.014), (13b)
losses and exclusions (56% vs. 11%, p = 0.004). As for the
other items, they all showed no statistical significant
differences, Table 4.
There are no differences in proportions of items in
STRICTA comparing studies in Chinese with that in
English (Chinese vs. English: 10.3 ± 1.8 vs. 9.6 ± 2.1,
p = 0.235), Table 3. Studies in Chinese have statistically
siginificant improvement in the item (1b) reasoning for
treatment provided (93% vs. 63%, p = 0.033) and (2d)
response sought (72% vs. 44%, p = 0.035) compared
with studies in English, whereas studies in English in the
item (5) practitioner background (6% vs. 50%, 0.004)
showed significant improvement compared with studies in
Chinese, Table 3.
Discussion
A wealth of evidence indicated the very inadequate
reporting of clinical researches. For example, informa-
tion on the method of random sequence generation, pri-
mary outcome, sample size calculation, randomization
stated in title, allocation concealment, and adequate
blinding was reported in 34, 53, 45, 33, 25, and 18% of
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616 reports indexed in PubMed in 2006, respectively
[84]. Especially, in RCTs of traditional Chinese medi-
cine that include herbal medicine, acupuncture and
other no medication therapies, reporting of the key
methods used for adequate randomization methods, ad-
equate allocation concealment, adequate blinding, both
adequate randomization methods and allocation con-
cealment used, and all three used was only 12, 7, 19, 4,
and 3% of 2580 reports, respectively [8]. Thus, several
guidelines have been recommended to help incomplete
and inaccurate reporting. The CONSORT statement
[11] is an evidence-based, minimum set of recommen-
dations for reporting randomized trials to alleviate the
problems arising from inadequate reporting of RCTs.
It offers a standard way for authors to prepare reports
of trial findings, facilitating their complete and trans-
parent reporting, and aiding their critical appraisal
and interpretation. The 2010 version of STRICTA
statement [12], an official extension to the CONSORT
statement, is the standards for reporting interventions
in clinical trials of acupuncture to facilitate transpar-
ency in published reports, enabling a better under-
standing and interpretation of results, aiding their
critical appraisal, and providing detail that is necessary
for replication.
In the present study, the quality of reporting of 70
RCTs on EA for stroke was generally moderate. The
CONSORT scores achieved by the included studies
ranged from 4.7 to 91.5% according to seven subdo-
mains, and the STRICTA scores across six subdomains
ranged from 16 to 84.5%. The central items in CON-
SORT of eligibility criterion, sample size calculation, pri-
mary outcome, method of randomization sequence
generation, allocation concealment, implementation of
randomization, description of blinding, and detailed stat-
istical methods are reported in 100, 3, 68, 37, 14, 10, 16,
and 97% of 70 reports, respectively. The reporting of de-
tail items in STRICTA of acupuncture rationale is 1a
(91%), 1b (86%) and 1c 0%; of needling details is 2a
(33%), 2b (97%), 2c (29%), 2d (64%), 2e (100%), 2f (55%)
and 2 g (66%); of treatment regimen is 3a (69%) and 3b
(100%); of other components of treatment is 4a (86%)
and 4b (13%); of practitioner background is item 5
(16%); of control intervention(s) is 6a (93%) and 6b
(10%). Based on the results of present study, several key
items need further improvement. First, a priori sample
size calculation can reduce the risk of an underpowered
(false-negative) result. However, in the present study
sample size calculation was reported in only 3% of all
the included trials. In fact, a survey of 215 studies
Table 4 Comparison of reporting quality between Chinese and English studies (CONSORT)
CONSORT item Chinese N = 54 English N = 16 Chinese vs. English
(P-value for difference)n %(n/54) 95%CI n %(n/16) 95%CI
Title 3 6c [1 to 15] 9 56 [30 to 80] 0.01
Methods
Trail design 48 89 [77 to 96] 10 63 [35 to 85] 0.061
Eligibility criteria 54 100 [93 to 100] 16 100 [79 to 100] _
Interventions 54 100 [93 to 100] 16 100 [79 to 100] _
Primary and secondary outcome 52 96 [87 to 100] 16 100 [79 to 100] 0.442
Sample size 3 6 [1 to 15] 1 6 [0 to 30] 0.918
Generation of random sequence 22 41 [28 to 55] 4 25 [7 to 52] 0.239
Allocation concealment 6 11 [4 to 23] 4 25 [7 to 52] 0.26
Blinding 4 7 [2 to 18] 7 44 [20 to 70] 0.014
Statistical methods 53 98 [90 to 100] 15 94 [70 to 100] 0.361
Results
Losses and exclusions 6 11 [4 to 23] 9 56 [30 to 80] 0.004
Recruitment 38 70 [56 to 82] 6 38 [15 to 65] 0.017
Numbers analysed 47 87 [75 to 95] 10 63 [35 to 85] 0.081
Harms 14 26 [15 to 40] 7 44 [20 to 70] 0.177
Limitations 4 7 [2 to 18] 6 38 [15 to 65] 0.33
Total mean scorea
15.2 ± 4.3
12.3 ± 3.6 0.05
aMean ± SD
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published in 2005 and 2006 in six general medical jour-
nals with high impact factors revealed that only 34% of
73 studies adequately described sample size calculations
[85]. If the trials were not conducted with pre-trial esti-
mation of sample size, there will be a lack of statistical
power to ensure appropriate estimation of the treatment
effect [86]. Thus, we suggest that an effort should be
made to increase transparency in sample size calcula-
tion. Second, successful randomisation reduces selection
bias at trial entry, which depends on two hinge steps-
adequate sequence generation and allocation conceal-
ment, and is the crucial component of high quality RCTs
[87]. In the present study method of randomization se-
quence generation, allocation concealment, and imple-
mentation of randomization is reported in only 37, 14,
and 10% of 70 RCTs, respectively. Inadequate or unclear
allocation concealment can exaggerate clinical effects in
41 and 30%, respectively [88]. Thus, proper randomization
should involve both random sequence generation and
complete implementation of allocation concealment to
minimize bias. Third, blinding is an essential method for
preventing research outcomes from being influenced by
either the placebo effect or the observer bias. Trials that
were not double blinded yielded larger estimates of treat-
ment effect than trials in which authors reported double
blinding (odds ratios exaggerated, on average by 17%)
[88]. In the present study, only 16% of 70 trials described
blinding procedure. Thus, more attentions should be paid
to this situation, especially in EA trials. Fourth, item 5 in
STRICTA is practitioner background that required de-
scription of participating acupuncturists in qualification or
professional affiliation, years in acupuncture practice,
other relevant experience. However, practitioner back-
ground was reported only in 16% trials. Thus, practitioner
qualifications should be completely reported, which could
increase the certainty with regard to treatment quality and
safe implementation of interventions.
Currently, the evidence from the study of manual and
electrical needle stimulation in acupuncture researched
by an executive board of the society for acupuncture re-
search [5] demonstrated that fundamental gaps existed
in the understanding of the mechanisms and relative ef-
fectiveness between manual and electrical acupuncture,
and these two techniques are not interchangeable. In
2006, Zhang et al. [9] evaluated the reporting quality of
74 RCTs on acupuncture for acute ischemic stroke, indi-
cating that the items in CONSORT of baseline demo-
graphic and clinical characteristics, method of random
sequence generation, allocation concealment, blinding
procedure, sample size calculation and intention-to-treat
(ITT) analysis was 73, 35, 8, 11, 5, and 7% of 74 RCTs
respectively; the items in STRICTA of the numbers of
needles inserted, the needle type, the depths of insertion,
the length of clinical experience, and the background of
the acupuncture practitioners was 5, 47, 35, 1, and 8% of
74 reports, respectively. Compared with zhang’s study
[9], the quality of reporting RCTs of EA for stroke in
present study is better. In 2014, Zhuang et al. [10] ana-
lyzed the quality of reporting of only 15 RCTs on acu-
puncture for subacute and chronic stroke, indicating
that poor reporting existed in terms of outcomes, sample
size, outcomes and estimation, ancillary analyses, with
positive rate less than 30% according to CONSORT
statement. Meanwhile, based on STRICTA statement,
item 4a: Details of other interventions and 4b: Setting
and context of treatment, the positive rate was 20 and
33% respectively. The quality of reporting of RCTs on
EA for stroke in present study is similar to the results of
Zhuang’s study [10]. This result indicates some improve-
ments in the quality of reporting of RCTs on both acu-
puncture and EA for stroke. One probable reason is that
reporting of several important aspects of trial methods
improved because the endorsement of the CONSORT
Statement and STRICTA statement. Another possible
reason is that Zhuang [10] studied only a small number
of selected RCTs, thus the conclusions may not be scien-
tifically sound and may be misleading. For present EA
study, the third possible reason is that EA is more read-
ily controlled, standardized and objectively measurable.
Additionally, EA is mainly considered as a method to
provide stronger treatment for nervous and mental dis-
eases like stroke. Thus, the use of EA for stroke research
can at least in part improve the standards of published
RCTs and is favored in stroke trials.
From the comparison of the included studies pub-
lished in Chinese and in English, we found the compli-
ance with CONSORT statement is unsatisfactory. Thus,
reporting of RCTs both in English and in Chinese should
endorse the CONSORT items as complete as possible.
In particular, studies published in Chinese need to im-
prove the reporting of (1a) title, (11a) blinding, and
(13b) losses and exclusions. For the STRICTA statement,
the proportions of fulfilling the items (1b) reasoning for
treatment and (2d) response sought in Chinese have sta-
tistically significant increase compared with those in
English. The main reasons are as follows: (1) acupunc-
ture has been practiced in China for over 2000 years
[89] and Chinese journals lay emphasis on reasoning for
treatment; (2) as one of the fundamental characteristics
of acupuncture, deqi has been used as a prerequisite for
clinical effects for a long time in China [90]. However,
the proportion of reporting item (5) practitioner back-
ground achieved statistically significant improvement in
English compared that in Chinese. The possible reason
is that English journals pay more attention to endorsing
the STRICTA statement [91]. Thus, both English and
Chinese journals need to endorse reporting acupuncture
RCTs based on the STRICTA checklist, especially item
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(5) practitioner background in Chinese and items (1b)
reasoning for treatment and (2d) response sought in
English, thereby actualizing an improvement in reporting
quality of RCTs for acupuncture.
There are some limitations in this study. First, the
searching languages are limited to only Chinese and
English during sample selection. The reports which are
published in other languages may be left out, and may
harm the reliability of our results. Second, we only dis-
cussed the reporting quality of RCTs on EA in the
present study, and compared with that of RCTs on acu-
puncture in the previous studies. The results may be po-
tentially misleading, and the direct comparison between
the reporting qualities of RCTs on manual acupuncture
for stroke with that of RCTs on EA is needed in the fu-
ture. Third, we carried out data extraction based on the
published paper itself. This approach meant that we
were unable to capture some primary trials with truly
good quality in trial methodology but poor reporting in
the final publication. Thus, when assessing trial quality
of such studies, reviewing research protocols and con-
tacting trialists for more information are needed.
Conclusions
Our study indicated that the overall quality of reporting of
RCTs on EA for stroke according to CONSORT and
STRICTA statement was moderate and the reporting
quality needs further improvement. In particular, it must be
emphasized that the poor quality reporting of crucial items
which includes sample size calculation, sequence generation,
allocation concealment, randomization implementation,
blinding, and practitioner background should be adequately
involved in RCTs on EA for stroke. More attention should
be given to the reporting of RCTs on EA for stroke to
ensure that all items in checklist of CONSORT and
STRICTA are clearly delineated, especially the central items
in the methodology. In addition, the use of EA for stroke
research can possibly improve the standards of published
RCTs when compared with manual acupuncture trials.
However, this need further direct comparative studies.
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